Although this reads well, this is mostly hot air before the March meeting of our PBAC. This will decide which drugs will be added to our PBS, making the drugs available to all Australians.
The drugs on the list are Daclatasvir, Harvoni and Sovaldi. AbbVie haven't bothered. Sovaldi has been rejected twice before- there has been a lot of pressure to get it approved this time.
Yearly notifications of new cases of HCV continues to rise. It is estimated that <10% of Australians that have tested +ve to HCV have been treated.
No deaths from HCV by 2030 is a brave statement. We'll still have cirrhotics developing HCC's, and liver failures requiring transplant. I'll let you know if Sovaldi is approved. Thanks.
suziq said
Jan 25, 2015
Looks like wonderful news from Australia--if it can be implemented. Interesting article.
Hi Susan,
Although this reads well, this is mostly hot air before the March meeting of our PBAC. This will decide which drugs will be added to our PBS, making the drugs available to all Australians.
The drugs on the list are Daclatasvir, Harvoni and Sovaldi. AbbVie haven't bothered. Sovaldi has been rejected twice before- there has been a lot of pressure to get it approved this time.
Yearly notifications of new cases of HCV continues to rise. It is estimated that <10% of Australians that have tested +ve to HCV have been treated.
No deaths from HCV by 2030 is a brave statement. We'll still have cirrhotics developing HCC's, and liver failures requiring transplant. I'll let you know if Sovaldi is approved. Thanks.
Looks like wonderful news from Australia--if it can be implemented. Interesting article.
Key role for Hep C Inquiry- By 2030 there should be no deaths in Australia related to hepatitis C
SuziQ